Wasatch Advisors LP Makes New Investment in Ralliant Corporation $RAL

Wasatch Advisors LP bought a new stake in shares of Ralliant Corporation (NYSE:RAL) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund bought 550,399 shares of the company’s stock, valued at approximately $40,526,000.

A number of other large investors also recently made changes to their positions in RAL. Teacher Retirement System of Texas lifted its stake in Ralliant by 6.9% in the fourth quarter. Teacher Retirement System of Texas now owns 570,878 shares of the company’s stock valued at $29,063,000 after buying an additional 36,800 shares during the period. Irenic Capital Management LP boosted its holdings in Ralliant by 424.1% during the first quarter. Irenic Capital Management LP now owns 1,740,218 shares of the company’s stock worth $72,376,000 after buying an additional 1,408,176 shares during the last quarter. Rokos Capital Management LLP acquired a new position in shares of Ralliant during the 1st quarter worth about $42,022,000. Phocas Financial Corp. grew its position in shares of Ralliant by 81.2% during the 4th quarter. Phocas Financial Corp. now owns 157,116 shares of the company’s stock worth $7,999,000 after buying an additional 70,403 shares during the period. Finally, California State Teachers Retirement System increased its stake in shares of Ralliant by 23.1% in the 1st quarter. California State Teachers Retirement System now owns 130,822 shares of the company’s stock valued at $5,441,000 after acquiring an additional 24,591 shares during the last quarter.

Ralliant Trading Up 3.2%

NYSE RAL opened at $71.60 on Wednesday. The firm has a market cap of $7.92 billion, a P/E ratio of -6.60, a P/E/G ratio of 2.58 and a beta of 1.61. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.52 and a quick ratio of 1.00. The stock’s 50-day moving average is $67.98 and its 200-day moving average is $55.06. Ralliant Corporation has a one year low of $37.27 and a one year high of $75.41.

Ralliant (NYSE:RAL) last released its quarterly earnings data on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, beating the consensus estimate of $0.63 by $0.05. Ralliant had a positive return on equity of 14.97% and a negative net margin of 56.38%.The business had revenue of $567.80 million for the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. Sell-side analysts anticipate that Ralliant Corporation will post 2.87 earnings per share for the current fiscal year.

Ralliant Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a $0.05 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Ralliant’s payout ratio is presently -1.84%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Morgan Stanley increased their price target on shares of Ralliant from $68.00 to $85.00 and gave the company an “overweight” rating in a research report on Tuesday, June 23rd. Barclays boosted their price objective on shares of Ralliant from $52.00 to $67.00 and gave the company an “overweight” rating in a report on Wednesday, May 13th. Royal Bank Of Canada increased their target price on shares of Ralliant from $71.00 to $73.00 and gave the stock a “sector perform” rating in a report on Friday, July 31st. Citigroup lifted their price target on shares of Ralliant from $81.00 to $82.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Finally, BMO Capital Markets assumed coverage on shares of Ralliant in a report on Monday, July 20th. They issued a “market perform” rating and a $78.00 price target for the company. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Ralliant currently has a consensus rating of “Moderate Buy” and a consensus price target of $75.70.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.